EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

The impact of baseline laboratory tests on the management of new-onset hypertension in primary care: A pilot study

Katia Kteich, Maria R Karam, Marouan Zoghbi, Mabel Aoun iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0324743 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS One, 2025. Verfasst von Katia Kteich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Saint-Joseph University of Beirut, Beirut, Lebanon. Hauptthemen laut MEDLINE: Hypertension. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertension is a key contributor to the global cardiovascular disease burden. In 2021, the World Health Organization (WHO) hypertension management guideline suggested baseline laboratory tests for patients with newly diagnosed hypertension but noted limited evidence in primary care contexts. This study evaluates the impact of baseline laboratory assessments on blood pressure control and comorbidities in newly diagnosed hypertensive patients.

Methods

This is a multicenter retrospective study that included all patients with new-onset hypertension between January 2015 and January 2020, followed in three primary health care centers until 2022. Data collection included 8 items of paraclinical tests performed at the diagnosis of hypertension: serum sodium, potassium and creatinine, lipid panel, electrocardiogram, glucose, HbA1c and urine dipstick. Complete workup was defined as having the 8 items checked and partial workup included 1–7 items. Blood pressure was assessed at one year and the final visit, which was beyond one year, in the two workup groups.

Results

Of 621 hypertensive patients, 107 with incident hypertension were analyzed (mean age: 54.8 ± 12.7 years; 58.9% women). A complete workup was done for 48 patients, partial for 52 and none for 7. Abnormalities detected included: 8.4% of patients with fasting blood glucose > 125 mg/dL, 7.5% with HbA1c > 6.5%, 1.9% with serum potassium < 3.5 mmoL/L, 54.2% with LDL Cholesterol > 100 mg/dL, 35.5% with serum creatinine > 0.8 mg/dL, and 7.5% with an estimated GFR < 60 mL/min/1.73 m2. Significant systolic blood pressure improvement was seen at 12 months in the complete workup group (129.9 ± 13.6 mmHg) vs. partial workup group (142.8 ± 18.9 mm Hg) ( P = 0.003). Men and smokers were tested more often than women and non-smokers.

Conclusion

Baseline laboratory tests in patients with newly diagnosed hypertension help unmask comorbidities such as chronic kidney disease, diabetes, and dyslipidemia. Our findings support the use of baseline laboratory testing in order to optimize blood pressure control and individual patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionHumansFemaleMaleMiddle AgedPrimary Health CarePilot ProjectsRetrospective StudiesAgedBlood PressureAdultGlycated HemoglobinBlood GlucoseCreatinine

Substanzen

Glycated HemoglobinBlood GlucoseCreatinine

Autor:innen und Institutionen

  • Faculty of Medicine, Saint-Joseph University of Beirut, Beirut, Lebanon.
  • Fondation AUB Santé, Lorient, France.

ORCID-Profile: Mabel Aoun

Zitieren

APA

Kteich, K., Karam, M. R., Zoghbi, M., & Aoun, M. (2025). The impact of baseline laboratory tests on the management of new-onset hypertension in primary care: A pilot study. PLOS One. https://doi.org/10.1371/journal.pone.0324743

Vancouver

Kteich K, Karam MR, Zoghbi M, Aoun M. The impact of baseline laboratory tests on the management of new-onset hypertension in primary care: A pilot study. PLOS One. 2025. doi:10.1371/journal.pone.0324743

BibTeX
@article{Kteich2025,
  author = {Kteich, Katia and Karam, Maria R and Zoghbi, Marouan and Aoun, Mabel},
  title = {The impact of baseline laboratory tests on the management of new-onset hypertension in primary care: A pilot study},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0324743}
}
Kostenlos starten →